Benign and malignant prostatic growths are associated with an increase in sialoconjugates (e.g. prostate-specific antigen (PSA)) in blood. Oxidative stress plays a crucial role in pathogenesis of various malignancies. The objective of this study was to evaluate oxidative stress parameters and protein-bound sialic acid level in sera of prostatic tumor cases and to asses for any association between them. Sera samples were collected and estimated for carbonylation of proteins, lipid peroxidation products, PSA and protein-bound sialic acid from 10 patients in each group with prostatic carcinoma (Ca prostate) and benign prostatic hyperplasia (BPH) along with 10 healthy male subjects of similar age group as control. In carcinoma prostate cases, lipid peroxides, protein carbonyls, protein-bound sialic acid and PSA were significantly increased compared to BPH and controls. There was significant association between oxidative stress parameters (lipid peroxide and protein carbonyl) and sialoconjugates (PSA and protein-bound sialic acid). In BPH cases, serum lipid peroxides and protein-bound sialic acid were significantly higher in comparison to controls and protein carbonyls were correlated with protein-bound sialic acid. ROC curve for sialic acid showed that it can be used as a marker to differentiate carcinoma prostate from benign growth of prostate at a cutoff level of 11.38 lg/mg protein with a sensitivity of 100% and specificity of 80%. We conclude that oxidative stress might be associated with the degree of sialylation of protein and graded changes in these parameters possibly unveil the pathogenic demarcation from benign to malignant condition of prostate.
Introduction
Oxidative stress has been implicated in the pathogenesis of various disorders including cancer. 1 Benign prostatic hyperplasia (BPH) and carcinoma of prostate (Ca prostate) are the most common conditions of prostate in ageing men. 2 Previous evidence suggested involvement of oxidative stress in the development of prostatic tumors. 3 Glycoprotein metabolism is altered in malignancies. 4 Sialic acid is the most common terminal carbohydrate in the glycan moiety of many glycoproteins. 5 For stabilization of glycoprotein structure and in determining surface characteristics of cells, sialic acid plays quite vital role. 6 Elevation of sialic acid concentration in serum has been observed in various malignancies. 7 Marth et al. 8 have reported difference in sialic acid levels between benign and malignant tumors. Prostate-specific antigen (PSA) and acid phosphatase, which are also sialic acid-containing glycoproteins normally present in circulation, are increased in both benign and malignant prostatic growth. [9] [10] [11] Previous evidences also suggest the appearance of novel sialoglycoprotein in Ca prostate. 12 These facts support the alteration in sialylation and/or sialic acid metabolism in neoplastic condition. However, there is hardly any evidence to justify them as marker for Ca prostate.
Several studies have related alteration in sialylation with oxidative stress. [13] [14] [15] [16] Pasquale et al. 17 demonstrated an association between lipid peroxides and PSA. Although oxidative stress and increase in sialoglycoprotein level and/or sialic acid content are reported in Ca prostate separately; however there are no reports correlating oxidative stress with sialylation parameters in both BPH and Ca prostate. Hence, the present study was designed to evaluate oxidative stress parameters (lipid peroxides and protein carbonyls) and sialylation level (protein-bound sialic acid and PSA) in sera of BPH and Ca prostate cases to assess the association between these parameters. Further, we have evaluated the potential of serum protein-bound sialic acid level as a marker to differentiate carcinoma prostate from BPH.
Materials and methods
Serum samples collected for evaluation of PSA from the clinically suspected cases of prostatic tumors (before digital examination or any biopsy procedure of prostate gland) were initially preserved at À201C After confirmation of diagnosis by histopathological examination the samples were categorized into either BPH or Ca prostate group based on the nature of the pathology. Ten such consecutive samples from patients with histopathologically confirmed Ca prostate (irrespective of their stage), which satisfied the exclusion criteria as well, constituted Ca prostate group. Similarly 10 samples from patients with benign growth were selected to form the BPH group. Samples were also collected from 10 healthy male volunteers of comparable age to represent the control group. Informed consent was obtained from each of these individuals before being registered in different study groups. Comorbidities like diabetes, infections, any systemic disorder and also persons on any kind of medication before collection of samples were considered as exclusion criteria for the study. Mean ages for Ca prostate, BPH and control groups were found to be 6774, 6573 and 6577 years, respectively. Each individual serum sample was analyzed for the levels of lipid peroxides, carbonyl content of proteins, PSA and protein-bound sialic acid.
Serum lipid peroxide was estimated spectrophotometrically using thiobarbituric acid 18 and results were expressed as nM/ml. Carbonylation of serum proteins was measured by modified Levine's method 19 and values were expressed as nM/ml protein. Sialic acid content of serum proteins was measured after acidhydrolytic cleavage of sialic acid from precipitated protein by modified Aminoff's method 20, 21 and expressed in mg/mg of protein. Serum PSA was estimated spectrophotometrically by micro-well Enzyme Immunoassay (Syntron Bioresearch, Inc., Carlsbad, CA, USA, following the manual) using enzyme-linked immunosorbent assay reader (Lab systems, Finland) and values were expressed as ng/ml. Serum protein levels of all the samples were estimated by Biuret method 22 using reagent kits (Agappe diagnostics, Thane, Maharastra, India) adapted to auto-analyzer (550 express plus, CibaCorning, Medfield, MA, USA).
Statistical analysis of the results was performed by one-way analysis of variance (ANOVA) followed by post hoc Tukey's HSD test to compare between different study groups. Correlation study among different parameters was carried out using Pearson's correlation analysis. ROC curve was plotted to assess whether protein-bound sialic acid can be used as a marker to differentiate Ca prostate from benign conditions of prostate. P-value less than 0.05 was considered significant. Statistical software SPSS 11.0 version was used to perform all the analysis. Table 1 shows mean and s.d. of serum protein carbonyl content, serum lipid peroxides, serum protein-bound sialic acid and PSA level in controls, BPH and carcinoma prostate cases. Serum lipid peroxides, protein carbonyl content, protein-bound sialic acid and PSA were significantly higher in carcinoma cases compared to BPH and controls. In BPH cases, serum lipid peroxides and protein-bound sialic acid levels were found to be increased significantly compared to controls. In both the clinical conditions we did not find any significant difference in total protein content in serum. These data suggest a state of oxidative stress and increased sialylation of serum proteins in prostatic tumors including BPH. Table 2 shows correlation analysis between oxidative stress parameters and sialic acid content of glycoproteins. In carcinoma prostate, lipid peroxide was significantly correlated with PSA (r ¼ 0.678, P ¼ 0.031), proteinbound sialic acid (r ¼ 0.887, P ¼ 0.001) and also with Oxidative stress, sialic acid in prostatic growth K Goswami et al
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protein carbonyl (r ¼ 0.654, P ¼ 0.040). Protein carbonyl content was significantly correlated with PSA (r ¼ 0.717, P ¼ 0.020) and protein-bound sialic acid (r ¼ 0.692, P ¼ 0.020). In BPH protein carbonyl content was significantly correlated with protein-bound sialic acid (r ¼ 0.638, P ¼ 0.047). These results suggest significant association between oxidative stress parameters and the protein-bound sialic acid content. ROC curve (figure not shown) for protein-bound sialic acid showed that at a cutoff level of 11.38 mg/mg protein this parameter could differentiate carcinoma prostate from benign growth of prostate with 100% sensitivity and 80% specificity.
Discussion
The data in the present study showed an increased sialic acid content of serum proteins in BPH and Ca prostate cases. Altered glycosylation of glycoconjugates is one of the important molecular changes that accompany malignant transformation. 23 Hence, it can be presumed that the information regarding alteration in levels of sialic acid content of glycoproteins may be useful in demarcating patients with malignant disease as well as to predict disease outcome.
In the present study, we found a significant increase in PSA levels in both BPH and Ca prostate, which is a known marker of these conditions. 10 Further, serum protein-bound sialic acid was recorded to be significantly increased both in malignant and benign condition and it also was correlated positively with PSA (r ¼ 0.690, P ¼ 0.027) only in carcinoma cases which suggests an association between alteration of sialoglycoprotein level and malignant transformation. Our findings were supported by earlier reports, which suggested an increased sialic acid and PSA in prostatic malignancy. 24 Previous studies have reported an alteration in prostate tissue glycosylation pattern in prostatic tumors. 25 Moreover, induction of sialylation response is claimed to be associated with tumor growth. 26 Although the cause for sialylation still remains unclear, several studies have attributed it to corresponding elevation in sialyl-transferase activities and an aberrant glycosylation process in tumor cells which contributes to an enhanced synthesis of sialic acid resulting in increased sialylation. 27 To assess oxidative stress in prostatic tumors we estimated lipid peroxides and carbonyl content of proteins in BPH and prostate carcinoma cases. Both lipid peroxides and protein carbonyls were considerably increased in carcinoma cases in comparison with controls and BPH cases. Lipid peroxides were correlated positively with protein carbonyls only in carcinoma prostate. These findings suggest that subjects with malignant disease were more prone for oxidative damage compared to those with benign disease. Our findings were justified by previous reports, which suggested involvement of oxidative stress in the development of malignant neoplasms of prostate. 3 In this study, we have applied rather stringent exclusion criteria to minimize the confounding effect from other possible sources of oxidative stress; however, presence of oxidatively relevant comorbidities may actually complicate the setting further.
Several studies have related oxidative stress with alteration in sialylation. [13] [14] [15] [16] In the present study, we found significant association between oxidative stress parameters and sialoglycoproteins. In carcinoma prostate, lipid peroxides and protein carbonyls were positively correlated with PSA and protein-bound sialic acid. In BPH, considerable correlation was found between protein carbonyls and protein-bound sialic acid. Moreover, there being no significant difference in total protein content among the study groups, these results suggest that oxidative stress might be responsible for increased sialylation of protein in prostatic tumors.
In this study protein-bound sialic acid was significantly increased in carcinoma cases compared to BPH and controls. Moreover, this parameter has shown significant increase in BPH cases also as compared to control level. Protein-bound sialic acid was found to differentiate BPH from Ca prostate at a cutoff level of 11.38 mg/mg serum protein with 100% sensitivity and 80% specificity suggesting that it can be used as an alternative marker along with PSA to differentiate between benign and malignant prostatic growths.
Thus, present study reveals that subjects with carcinoma prostate exhibit more oxidative damage as compared to those with BPH (as evidenced by the significant graded increase in the levels of both the oxidative parameters from benign to malignant tumor cases). This study further suggests that such oxidative stress might be responsible for increased sialylation in these conditions. Further studies are needed to explore the role of oxidative stress in sialoglycoprotein metabolism in prostatic neoplasm. It would also be interesting to study alteration in sialic acid levels with extent of disease, its impact on prognosis and response to therapy in prostatic tumors. The assay of sialyl-transferase activity along with sialic acid levels can throw more light in better understanding of mechanism of elevation of sialic acid during different stages of benign and malignant disease of prostate.
